Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

A new Trump administration rule bars immigrants living in the US under Deferred Action for Childhood Arrivals (DACA) from buying health insurance from Affordable Care Act marketplaces.

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.

Subcutaneous isatuximab plus bortezomib, lenalidomide, and dexamethasone is effective in transplant-ineligible, newly diagnosed multiple myeloma.

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu as a second-line therapy for HER2-positive metastatic breast ...

New and additional prescribing of opioids has decreased among patients with newly diagnosed cancer, a study suggests.

A growing number of patients are getting caught in the middle of contract disputes between hospitals and insurers.

Eric K. Singhi, MD, is a thoracic oncologist at MD Anderson Cancer Center in Houston and one of Cancer Therapy Advisor’s editorial board members. He shares his top 5 presentations from the 2025 World ...

“As the only physician in the [Pennsylvania] General Assembly, I have seen the rapid growth of AI usage in health care in real time,” said Democratic Pennsylvania state Rep. Arvind Venkat in a ...

A MyChart-driven data collection strategy proved acceptable, appropriate, and feasible for gathering SOGI information from patients at a cancer center in the South,” the researchers wrote.

Keytruda Qlex is a fixed combination of pembrolizumab, a PD-1-blocking antibody, and berahyaluronidase alfa, a variant of human hyaluronidase. The addition of berahyaluronidase enhances dispersion and ...

The FDA is moving to abandon a decades-old policy of asking advisory committees to review drug applications, and critics say ...